Zoetis (ZTS) Stock: Charts & Financials

Zoetis Inc. (ZTS)ZTSZoetis Inc.

About Zoetis Inc.

Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.

Parsippany, NJ

14,500 employees

www.zoetis.com

Healthcare / Drug Manufacturers - General

Sector: Healthcare
Industry: Drug Manufacturers - General
CEO: Kristin C. Peck

View full financials

Quarterly Report	TTM	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024	Quarter ended Jun 2024
Total Current Assets	6.47B	6.47B	6.77B	6.58B	5.92B	5.88B	5.99B	6.28B	6.20B
Cash & Cash Equivalents	1.94B	1.94B	2.31B	2.08B	1.44B	1.72B	1.99B	1.71B	1.57B
Short-Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	1.94B	1.94B	2.31B	2.08B	1.44B	1.72B	1.99B	1.71B	1.57B
Accounts Receivable	1.51B	1.51B	1.59B	1.54B	1.54B	1.36B	1.32B	1.41B	1.38B
Inventory	2.55B	2.55B	2.43B	2.46B	2.44B	2.37B	2.31B	2.42B	2.45B
Total Assets	15.15B	15.15B	15.47B	15.16B	14.48B	14.10B	14.24B	14.36B	14.16B
Property, Plant & Equipment	4.00B	4.00B	3.97B	3.89B	3.84B	3.66B	3.61B	3.52B	3.42B
Goodwill	2.78B	2.78B	2.77B	2.76B	2.76B	2.72B	2.72B	2.74B	2.74B
Intangible Assets	959.00M	959.00M	998.00M	1.04B	1.07B	1.08B	1.13B	1.19B	1.23B
Long-Term Investments	0.00	0.00	0.00	1.00M	0.00	0.00	30.00M	0.00	0.00
Total Current Liabilities	2.05B	2.05B	2.23B	1.81B	3.37B	3.38B	3.41B	1.70B	1.80B
Accounts Payable	507.00M	507.00M	487.00M	410.00M	508.00M	420.00M	433.00M	404.00M	420.00M
Short-Term Debt	0.00	0.00	53.00M	0.00	1.35B	1.35B	1.35B	0.00	0.00
Total Liabilities	11.92B	11.92B	12.14B	9.76B	9.50B	9.44B	9.47B	9.12B	9.21B
Long-Term Debt	9.04B	9.04B	9.24B	7.07B	5.23B	5.23B	5.22B	6.57B	6.56B
Total Debt	9.24B	9.24B	9.49B	7.27B	6.79B	6.75B	6.74B	6.75B	6.74B
Net Debt (Cash)	7.30B	7.30B	7.18B	5.19B	5.36B	5.03B	4.76B	5.04B	5.17B
Total Shareholders' Equity	3.23B	3.23B	3.33B	5.40B	4.98B	4.66B	4.77B	5.23B	4.97B
Common Stock	5.00M	5.00M	5.00M	5.00M	5.00M	5.00M	5.00M	5.00M	5.00M
Retained Earnings	14.18B	14.18B	13.74B	13.59B	12.87B	12.38B	11.97B	11.81B	11.12B
Current Ratio	3.15	3.15	3.03	3.64	1.76	1.74	1.75	3.69	3.45
Debt to Equity Ratio	2.86	2.86	2.85	1.35	1.36	1.45	1.41	1.29	1.36

Quarterly Report

TTM

Quarter ended Mar 2026

Quarter ended Dec 2025

Quarter ended Sep 2025

Quarter ended Jun 2025

Quarter ended Mar 2025

Quarter ended Dec 2024

Quarter ended Sep 2024

Quarter ended Jun 2024

Total Current Assets

6.47B

6.77B

6.58B

5.92B

5.88B

5.99B

6.28B

6.20B

Cash & Cash Equivalents

1.94B

2.31B

2.08B

1.44B

1.72B

1.99B

1.71B

1.57B

Short-Term Investments

0.00

Cash & Short-Term Investments

1.94B

2.31B

2.08B

1.44B

1.72B

1.99B

1.71B

1.57B

Accounts Receivable

1.51B

1.59B

1.54B

1.36B

1.32B

1.41B

1.38B

Inventory

2.55B

2.43B

2.46B

2.44B

2.37B

2.31B

2.42B

2.45B

Total Assets

15.15B

15.47B

15.16B

14.48B

14.10B

14.24B

14.36B

14.16B

Property, Plant & Equipment

4.00B

3.97B

3.89B

3.84B

3.66B

3.61B

3.52B

3.42B

Goodwill

2.78B

2.77B

2.76B

2.72B

2.74B

Intangible Assets

959.00M

998.00M

1.04B

1.07B

1.08B

1.13B

1.19B

1.23B

Long-Term Investments

0.00

1.00M

0.00

30.00M

0.00

Total Current Liabilities

2.05B

2.23B

1.81B

3.37B

3.38B

3.41B

1.70B

1.80B

Accounts Payable

507.00M

487.00M

410.00M

508.00M

420.00M

433.00M

404.00M

420.00M

Short-Term Debt

0.00

53.00M

0.00

1.35B

0.00

Total Liabilities

11.92B

12.14B

9.76B

9.50B

9.44B

9.47B

9.12B

9.21B

Long-Term Debt

9.04B

9.24B

7.07B

5.23B

5.22B

6.57B

6.56B

Total Debt

9.24B

9.49B

7.27B

6.79B

6.75B

6.74B

6.75B

6.74B

Net Debt (Cash)

7.30B

7.18B

5.19B

5.36B

5.03B

4.76B

5.04B

5.17B

Total Shareholders' Equity

3.23B

3.33B

5.40B

4.98B

4.66B

4.77B

5.23B

4.97B

Common Stock

5.00M

Retained Earnings

14.18B

13.74B

13.59B

12.87B

12.38B

11.97B

11.81B

11.12B

Current Ratio

3.15

3.03

3.64

1.76

1.74

1.75

3.69

3.45

Debt to Equity Ratio

2.86

2.85

1.35

1.36

1.45

1.41

1.29

1.36

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Total Current Assets	6.77B	5.99B	6.34B	7.51B	6.93B	6.61B	4.75B	4.40B
Cash & Cash Equivalents	2.31B	1.99B	2.04B	3.58B	3.48B	3.60B	1.93B	1.60B
Short-Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	99.00M
Cash & Short-Term Investments	2.31B	1.99B	2.04B	3.58B	3.48B	3.60B	1.93B	1.70B
Accounts Receivable	1.59B	1.32B	1.30B	1.22B	1.13B	1.01B	1.09B	1.04B
Inventory	2.43B	2.31B	2.56B	2.35B	1.92B	1.63B	1.41B	1.39B
Total Assets	15.47B	14.24B	14.29B	14.93B	13.90B	13.61B	11.54B	10.78B
Property, Plant & Equipment	3.97B	3.61B	3.43B	2.97B	2.60B	2.39B	2.13B	1.66B
Goodwill	2.77B	2.72B	2.76B	2.75B	2.68B	2.69B	2.59B	2.52B
Intangible Assets	998.00M	1.13B	1.34B	1.38B	1.47B	1.71B	1.89B	2.05B
Long-Term Investments	0.00	30.00M	0.00	0.00	0.00	0.00	0.00	0.00
Total Current Liabilities	2.23B	3.41B	1.89B	3.17B	1.80B	2.17B	1.81B	1.22B
Accounts Payable	487.00M	433.00M	411.00M	405.00M	436.00M	457.00M	301.00M	313.00M
Short-Term Debt	53.00M	1.35B	3.00M	1.35B	0.00	604.00M	500.00M	9.00M
Total Liabilities	12.14B	9.47B	9.29B	10.52B	9.36B	9.84B	8.84B	8.59B
Long-Term Debt	9.24B	5.22B	6.56B	6.55B	6.59B	6.59B	5.95B	6.44B
Total Debt	9.49B	6.74B	6.75B	8.09B	6.74B	7.36B	6.61B	6.45B
Net Debt (Cash)	7.18B	4.76B	4.72B	4.51B	3.26B	3.76B	4.68B	4.86B
Total Shareholders' Equity	3.33B	4.77B	5.00B	4.41B	4.54B	3.77B	2.71B	2.19B
Common Stock	5.00M	5.00M	5.00M	5.00M	5.00M	5.00M	5.00M	5.00M
Retained Earnings	13.74B	11.97B	10.29B	8.67B	7.19B	5.66B	4.43B	3.27B
Current Ratio	3.03	1.75	3.36	2.37	3.86	3.05	2.63	3.60
Debt to Equity Ratio	2.85	1.41	1.35	1.84	1.48	1.95	2.44	2.95

Annual Report

12/31/2025

12/31/2024

12/31/2023

12/31/2022

12/31/2021

12/31/2020

12/31/2019

12/31/2018

Total Current Assets

6.77B

5.99B

6.34B

7.51B

6.93B

6.61B

4.75B

4.40B

Cash & Cash Equivalents

2.31B

1.99B

2.04B

3.58B

3.48B

3.60B

1.93B

1.60B

Short-Term Investments

0.00

99.00M

Cash & Short-Term Investments

2.31B

1.99B

2.04B

3.58B

3.48B

3.60B

1.93B

1.70B

Accounts Receivable

1.59B

1.32B

1.30B

1.22B

1.13B

1.01B

1.09B

1.04B

Inventory

2.43B

2.31B

2.56B

2.35B

1.92B

1.63B

1.41B

1.39B

Total Assets

15.47B

14.24B

14.29B

14.93B

13.90B

13.61B

11.54B

10.78B

Property, Plant & Equipment

3.97B

3.61B

3.43B

2.97B

2.60B

2.39B

2.13B

1.66B

Goodwill

2.77B

2.72B

2.76B

2.75B

2.68B

2.69B

2.59B

2.52B

Intangible Assets

998.00M

1.13B

1.34B

1.38B

1.47B

1.71B

1.89B

2.05B

Long-Term Investments

0.00

30.00M

0.00

Total Current Liabilities

2.23B

3.41B

1.89B

3.17B

1.80B

2.17B

1.81B

1.22B

Accounts Payable

487.00M

433.00M

411.00M

405.00M

436.00M

457.00M

301.00M

313.00M

Short-Term Debt

53.00M

1.35B

3.00M

1.35B

0.00

604.00M

500.00M

9.00M

Total Liabilities

12.14B

9.47B

9.29B

10.52B

9.36B

9.84B

8.84B

8.59B

Long-Term Debt

9.24B

5.22B

6.56B

6.55B

6.59B

5.95B

6.44B

Total Debt

9.49B

6.74B

6.75B

8.09B

6.74B

7.36B

6.61B

6.45B

Net Debt (Cash)

7.18B

4.76B

4.72B

4.51B

3.26B

3.76B

4.68B

4.86B

Total Shareholders' Equity

3.33B

4.77B

5.00B

4.41B

4.54B

3.77B

2.71B

2.19B

Common Stock

5.00M

Retained Earnings

13.74B

11.97B

10.29B

8.67B

7.19B

5.66B

4.43B

3.27B

Current Ratio

3.03

1.75

3.36

2.37

3.86

3.05

2.63

3.60

Debt to Equity Ratio

2.85

1.41

1.35

1.84

1.48

1.95

2.44

2.95

Balance Sheet

Quarterly Balance Sheet (USD)

Annual Balance Sheet (USD)